CATALOGO DEI PRODOTTI DELLA RICERCA

COLOMBATTI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.747
EU - Europa 7.536
AS - Asia 5.418
SA - Sud America 802
AF - Africa 122
Continente sconosciuto - Info sul continente non disponibili 85
OC - Oceania 13
Totale 24.723
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.397
RU - Federazione Russa 2.391
GB - Regno Unito 2.231
SG - Singapore 2.212
CN - Cina 1.571
BR - Brasile 659
IT - Italia 546
SE - Svezia 474
HK - Hong Kong 439
VN - Vietnam 435
DE - Germania 378
FI - Finlandia 376
FR - Francia 353
IE - Irlanda 348
CA - Canada 201
KR - Corea 161
UA - Ucraina 132
BD - Bangladesh 125
IN - India 90
JP - Giappone 68
TR - Turchia 65
NL - Olanda 58
AR - Argentina 53
MX - Messico 52
BE - Belgio 46
ES - Italia 44
IQ - Iraq 37
PL - Polonia 34
ZA - Sudafrica 34
IR - Iran 30
NG - Nigeria 29
ID - Indonesia 27
CO - Colombia 21
EC - Ecuador 21
AT - Austria 19
CR - Costa Rica 18
PK - Pakistan 17
PH - Filippine 16
SA - Arabia Saudita 16
JM - Giamaica 14
LT - Lituania 14
MA - Marocco 13
AU - Australia 12
MY - Malesia 12
UZ - Uzbekistan 12
VE - Venezuela 12
RO - Romania 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 9
CL - Cile 9
NI - Nicaragua 9
PT - Portogallo 9
UY - Uruguay 9
AZ - Azerbaigian 8
EG - Egitto 8
GT - Guatemala 8
IL - Israele 8
NP - Nepal 8
SV - El Salvador 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
CW - ???statistics.table.value.countryCode.CW??? 7
HN - Honduras 7
JO - Giordania 7
KZ - Kazakistan 7
PE - Perù 7
PR - Porto Rico 7
CZ - Repubblica Ceca 6
GR - Grecia 6
HR - Croazia 6
KE - Kenya 6
PA - Panama 6
PY - Paraguay 6
AL - Albania 5
ET - Etiopia 5
TW - Taiwan 5
AM - Armenia 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
DK - Danimarca 4
DZ - Algeria 4
EU - Europa 4
HU - Ungheria 4
KW - Kuwait 4
LV - Lettonia 4
PS - Palestinian Territory 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BO - Bolivia 3
BS - Bahamas 3
DO - Repubblica Dominicana 3
EE - Estonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CM - Camerun 2
CY - Cipro 2
GH - Ghana 2
GP - Guadalupe 2
Totale 24.612
Salva come PNG Salva come JPEG
Città #
Southend 1.866
Ashburn 1.514
Singapore 1.206
Jacksonville 1.018
Chandler 875
Dallas 792
Moscow 775
San Jose 742
Woodbridge 723
Ann Arbor 489
Hong Kong 423
Dublin 348
Houston 276
Beijing 271
Council Bluffs 253
The Dalles 253
Los Angeles 236
Verona 226
Buffalo 183
New York 166
Wilmington 152
Ho Chi Minh City 138
Princeton 133
Lawrence 132
Jinan 123
Nanjing 113
Hanoi 103
Helsinki 101
Shenyang 101
Santa Clara 84
Tianjin 80
São Paulo 79
Munich 67
Boardman 65
Hebei 64
Montreal 58
Tokyo 58
Columbus 57
Seattle 53
Milan 51
Orem 47
Brussels 45
Changsha 44
Sindelfingen 42
Zhengzhou 42
Philadelphia 40
Denver 37
London 37
Taizhou 37
Chennai 36
San Francisco 35
Cambridge 34
Ningbo 34
Toronto 34
Chicago 32
Hangzhou 32
Nanchang 32
Fairfield 31
Guangzhou 31
Haikou 30
Jiaxing 30
Seoul 30
Annandale 29
Turku 29
Amsterdam 28
Atlanta 28
Brooklyn 28
Rome 28
Warsaw 28
Abuja 27
Falls Church 27
Norwalk 25
Frankfurt am Main 24
Johannesburg 24
Stockholm 24
Taiyuan 24
Providence 23
Bologna 22
Da Nang 22
Fuzhou 22
Boston 20
Manchester 20
Phoenix 20
Lancaster 19
Redondo Beach 19
Auburn Hills 18
Las Vegas 17
Rio de Janeiro 17
Belo Horizonte 15
Falkenstein 15
Jakarta 15
Lanzhou 15
Mexico City 15
San José 15
Brasília 14
Detroit 14
Haiphong 14
Poplar 14
Barnet 13
Vancouver 13
Totale 16.023
Salva come PNG Salva come JPEG
Nome #
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 320
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 319
Anti PSMA immunotoxins activity against prostate cancer cell lines. 305
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 303
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. 282
Anti-PSMA-Immunotoxins: a new therapeutical strategy for selective targeting of toxins to prostate cancer cells. 281
Immunotoxins and other conjugates: preparation and general characteristics. 279
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 276
Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates 261
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 261
Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment 261
Reductive activation of ricin and ricin-A chain immunotoxins by Protein Disulfide Isomerase and Thioredoxin Reductase system. 258
Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity 253
Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction 250
Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing. 247
Adhesion of immature and mature T cells induces in human thymic epithelial cells (TEC) activation of IL-6 gene trascription factors (NF-kappaB and NF-IL6) and IL-6 gene expression: role of alpha3beta1 and alpha6beta4 integrins. 247
FLUORESCENT ASSAY TO TEST PROTEIN DISULFIDE ISOMERASE ACTIVITY INDUCED BY THIOREDOXIN REDUCTASE. 246
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 245
Fluorescent Assay to Demonstrate the Interaction of Thioredoxin Reductase and Protein Disulfide Isomerase. 243
Anti-prostate specific membrane antigen targeted gold nanoparticles in tumor therapy and diagnosis 243
Cytoreductive effects of anti-transferrin receptor immunotoxin in a multicellular tumor spheroid model 242
Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model 239
A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia 238
Cooperation of Prostate Specific Membrane Antigen with beta 1 integrin promotes the survival of aggressive prostate cancer cells 235
EpCAM a possible target for immunotoxin treatments of PSMA positive and negative prostate cancer cells 232
Distribution of endocytosed molecules to intracellular acidic environments correlates with immunotoxin activity 228
A fluorescence-based assay for the reductase activity of protein disulfide isomerase. 227
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer 226
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 225
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 224
Characterization of In-111-labeled site-specifically conjugated anti-PSMA antibody-drug conjugates for treatment of PSMA-expressing tumors 224
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi 219
Human immune response to ricin A-chain: identification of T-cell and B-cell epitopes. 215
Sensitivity of human leukemia cells in exponential or stationary growth phase to anti-CD5 immunotoxins. Role of intracellular processing events 214
Protein Disulfide Isomerase and Thioredoxin Reductase: a ricin disulfide reducing system in the endoplasmic reticulum. 211
Investigation of Properties of Anti-Prostate Specific Membrane Antigen-targeted Gold Nanoparticles as Drug Carriers in Tumor Therapy 211
Biodistribution of In-111-labeled D2B IgG, F(ab’)2 and Fab fragments in nude mice bearing human prostate cancer xenografts 210
The prostate specific membrane antigen regulates the expression of IL-6 and CCL-5 in prostate tumour cells by activating the MAPK pathways 210
Disposition of intrathecally administered immunotoxins in rats. A preliminary report 209
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin 209
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 207
The Filamin A-mediated cooperation of Prostate Specific Membrane Antigen (PSMA) with beta1 integrin promotes the survival of aggressive prostate cancer cells. 206
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating the MAPK pathways. 205
Tumor Targeting with Guided Silica Nanopartilces for Prostate Cancer Therapy 202
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 201
Anti-TNF? therapy in rheumatoid arthritis and autoimmunity 200
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 199
Discriminatory role of detergent-resistant membranes in the dimerization and endocytosis of prostate-specific membrane antigen 199
Late generation lentiviral vectors: evaluation of inflammatory potential in human airway epithelial cells. 198
Chemical conjugation of ΔF508-CFTR corrector deoxyspergualin to transporter human serum albumin enhances its ability to rescue Cl- channel functions. 197
Top-down synthesis of multifunctional iron oxide nanoparticles for macrophage labelling and manipulation 195
Mechanisms involved in serum-dependent inactivation of the immunotoxin enhancers monensin and carrier-protein-monensin 193
T cell immune function in newborn infants 193
Standardization of in vitro synthesis and detection of HIV-1-specific antibodies 193
Potentiation of cytotoxic heteroconjugates by monensin-carrier proteins 193
Prostate Specific Membrane Antigen (PSMA) associates with Filamin A, beta1 integrin, pp130CAS and pSrc thus regulating the activation of beta1 integrin and the survival of prostate cancer cells. 193
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection 192
Cloning and characterisation of canine prostate-specific membrane antigen 191
Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors 191
Monoclonal antibodies against ricin: effects on toxin function 190
Human MBP-specific T cells regulate IL-6 gene expression in astrocytes through cell-cell contacts and soluble factors 190
Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. 190
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 188
Hybridoma cells containing intracellular anti-ricin antibodies show ricin meets secretory antibody before entering the cytosol 186
N-terminal deletion affetcs catalytic activity of saporin toxin. 186
The Proinflammatory Cytokine, IL-6, and its Interference with bFGF Signaling and PSMA in Prostate Cancer Cells. 186
Plasmonic Nanostructures for SERRS Multiplexed Identification of Tumor-Associated Antigens 186
Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems 186
Prostate-specific membrane antigen associates already in the endoplasmic reticulum with lipid microdomains 186
Human glioma cell lines: tumour associated antigens distribution and sensitivity to antibody-toxin or ligand-toxin conjugates. A preliminary report 183
Reductive activation of type 2 ribosome inactivating proteins (RIPs 2) is promoted by transmembrane thioredoxin-related protein (TMX) 182
Sensitivity of human glioma cells to cytotoxic heteroconjugates 181
Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. 179
Magneto-Plasmonic Au-Fe alloy nanoparticles designed for multimodal SERS-MRI-CT imaging 178
Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines 177
SERS IMAGING OF CANCER CELLS WITH ANTIBODY FUNCTIONALIZED GOLD NANOPARTICLES 175
Lymphocyte phenotypic subsets in umbilical cord blood compared to peripheral blood from related mothers 175
Targeted Silica Nanoparticles for PhotoDynamic Therapy (PDT) 174
Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas 173
Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen 173
Lipid interaction of diphtheria toxin and mutants with altered fragment B. 2. Hydrophobic photolabelling and cell intoxication 172
Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof 171
Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with viral structures 171
Problems and potentials in immunotoxin therapy 170
Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin 168
Internalization and intracellular fate of anti-CD5 monoclonal antibody and anti-CD5 ricin A-chain immunotoxin in human leukemic T cells 168
Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA) 167
Peptide analogues of a T-cell epitope of ricin toxin A-chain prevent agonist-mediated human T-cell response in vitro. 166
Identification of Ricin A chain HLA II-restricted epitopes by human T-cell clones. 166
Prostate-specific membrane antigen (PSMA) associates early in the endoplasmic reticulum with lipid microdomains 165
IL-6 gene expression in human astrocytes is enhanced after adhesion to MBP-specific T-cells: role of beta1 integrin and IFN-gamma in the induction of NF-kB and IRF-1 binding activity 165
Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures 161
Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems. 160
Thy 1.2+ leukemia cells eradicated from in vitro leukemia-bone marrow cell mixtures by antibody-toxin conjugates 159
Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection 157
Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry 157
Preliminary results of Soft X-ray Absorption Near Edge Spectroscopy of sulfur in biomolecules. 156
Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin 152
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones 149
SERS labels for quantitative assays: application to the quantification of gold nanoparticles uptaken by macrophage cells 148
Totale 20.648
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.403
article - articoli 53.311
book - libri 0
conference - conferenze 18.678
curatela - curatele 0
other - altro 0
patent - brevetti 1.081
selected - selezionate 0
volume - volumi 2.333
Totale 150.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022633 0 0 0 0 39 36 29 78 43 29 110 269
2022/20232.478 175 230 210 402 239 577 89 200 262 12 61 21
2023/2024991 55 93 82 134 111 144 30 71 13 80 124 54
2024/20253.027 176 201 65 466 209 126 185 124 469 191 260 555
2025/20268.903 598 528 868 1.340 2.148 621 917 415 608 510 152 198
2026/20271.783 143 251 434 955 0 0 0 0 0 0 0 0
Totale 24.723